Ro 67-7476

CAS No. 298690-60-5

Ro 67-7476 ( —— )

Catalog No. M17468 CAS No. 298690-60-5

Ro 67-7476 is a positive allosteric modulator of mGlu1 receptors. No activity at human mGlu1 receptors. Potentiates glutamate-induced calcium release with EC 50 of 60.1 nM.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 39 In Stock
5MG 77 In Stock
10MG 120 In Stock
25MG 244 In Stock
50MG 441 In Stock
100MG 644 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ro 67-7476
  • Note
    Research use only, not for human use.
  • Brief Description
    Ro 67-7476 is a positive allosteric modulator of mGlu1 receptors. No activity at human mGlu1 receptors. Potentiates glutamate-induced calcium release with EC 50 of 60.1 nM.
  • Description
    Ro 67-7476 is a positive allosteric modulator of mGlu1 receptors. No activity at human mGlu1 receptors. Potentiates glutamate-induced calcium release with EC 50 of 60.1 nM.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    mGluR1
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    298690-60-5
  • Formula Weight
    319.39
  • Molecular Formula
    C17H18FNO2S
  • Purity
    98%
  • Solubility
    DMSO : ≥ 40 mg/mL; 125.24 mM
  • SMILES
    N1([C@@H](CCC1)c1ccc(cc1)F)S(=O)(=O)c1ccc(cc1)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hemstapat K et al. Mol Pharmacol. 2006 Aug, 70(2), 616-26
molnova catalog
related products
  • BIMU 8

    BIMU 8 is a selective agonist of 5-HT4 with EC50s of 18 nM, 77 nM, and 540 nM for wild-type 5HT4 receptor, T3.36A, and W6.48A mutant 5-HT4.

  • MM 77 dihydrochlorid...

    MM 77 dihydrochloride is an effecitve 5-HT1A receptor postsynaptic antagonist with anxiolytic-like activity.

  • Citalopram HBr

    Citalopram hydrobromide belongs to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs).